How have TRLS shares performed in 2024?

Trellus Health's stock was trading at GBX 3.25 at the beginning of the year. Since then, TRLS shares have decreased by 40.3% and is now trading at GBX 1.94. View the best growth stocks for 2024 here .

How do I buy shares of Trellus Health?

Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:TRLS

Trellus Health (TRLS) Share Price, News & Analysis

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Free TRLS Stock Alerts

GBX 1.94

+0.04 (+2.11%)

(As of 05/3/2024 ET)

Compare

Today's Range: 1.60
▼
1.94
50-Day Range: 1.60
▼
3.75
52-Week Range: 1.50
▼
9.65

Volume: 539,815 shs
Average Volume: 320,477 shs
Market Capitalization: £3.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get Trellus Health alerts:

Ad Altimetry

Urgent Nvidia Warning

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

TRLS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRLS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive TRLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trellus Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: LON:TRLS
CUSIP: N/A
CIK: N/A
Web: www.trellushealth.com
Phone: 800-866-4165
Fax: N/A
Employees: 31
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.03)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-6,340,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -28.43%
Return on Assets: -18.41%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 15.69
Quick Ratio: 17.11

Sales & Book Value

Annual Sales: £35,000.00
Price / Sales: 89.52
Cash Flow: GBX 2.56 per share
Price / Cash Flow: 0.76
Book Value: GBX 12 per share
Price / Book: 0.16

Miscellaneous

Outstanding Shares: 161,510,000
Free Float: N/A
Market Cap: £3.13 million
Optionable: Not Optionable
Beta: 0.10

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Dr. Marla Cindy Dubinsky M.D.
Co-Founder, CEO & Director
Dr. Laurie Keefer Ph.D.
Co-Founder & Chair of Scientific Advisory Board
Ms. Joy Bessenger B.A.
Chief Financial Officer
Aled Stevenson
Chief Operating Officer
Jamey Hancock
Chief Technology Officer
Amy Murphy
Director of Human Resources
Dr. Andres Jimenez M.B.A.
M.D., M.S., Chief Medical Information Officer
Leah Conley M.B.A.
Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board
Mr. Salim Gulamabbas Hamir F.C.A.
Company Secretary

Key Competitors

View All Competitors

TRLS Stock Analysis - Frequently Asked Questions

How have TRLS shares performed in 2024?: Trellus Health's stock was trading at GBX 3.25 at the beginning of the year. Since then, TRLS shares have decreased by 40.3% and is now trading at GBX 1.94.
View the best growth stocks for 2024 here.
How do I buy shares of Trellus Health?: Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:TRLS) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial